Abstract | SCOPE: Se-methyl-L- selenocysteine (MSC), a naturally occurring organoselenium compound, has shown cancer chemopreventive activity against several types of cancer. Herein, the effect of MSC on the inflammatory response in lipopolysaccharide (LPS)-activated murine RAW 264.7 macrophage cells was investigated. METHODS AND RESULTS: The present results demonstrated that MSC markedly inhibited LPS-induced production of NO in a dose-dependent pattern with decreased mRNA and protein levels of inducible nitric oxide synthase (iNOS). MSC also reduced nuclear translocation of p65 and p50 subunits of nuclear factor-κB (NF-κB), a critical transcription factor necessary for iNOS expression, accompanied with downregulation of LPS-triggered NF-κB-dependent gene expression evaluating by a luciferase reporter. Inhibition of nuclear translocation by MSC might result from the prevention of the inhibitor of NF-κB from phosphorylation and consequent degradation via suppression inhibition of phosphorylation of IκB kinase α/β. Exploring the action mechanism involved, MSC can reduce the phosphorylation/activation of mitogen-activated protein kinases (MAPKs) related to NF-κB activation induced by LPS, including p38 MAPK and c-Jun N-terminal kinase in RAW 264.7 cells. CONCLUSION: MSC might contribute to the potent anti-inflammatory effect in LPS-activated RAW 264.7 cells via downregulation of NF-κB activation and iNOS expression, suggesting that MSC may be considered as a therapeutic candidate for chronic inflammatory diseases.
|
Authors | Min-Hsiung Pan, Huei-Mei Hong, Chih-Li Lin, Ai-Zhi Jhang, Jie-Heng Tsai, Vladimir Badmaev, Kalyanam Nagabhushanam, Chi-Tang Ho, Wei-Jen Chen |
Journal | Molecular nutrition & food research
(Mol Nutr Food Res)
Vol. 55
Issue 5
Pg. 723-32
(May 2011)
ISSN: 1613-4133 [Electronic] Germany |
PMID | 21213327
(Publication Type: Journal Article)
|
Copyright | Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
Chemical References |
- Anticarcinogenic Agents
- I-kappa B Proteins
- Lipopolysaccharides
- NF-kappa B
- Nfkbia protein, mouse
- Organoselenium Compounds
- RNA, Messenger
- Selenocysteine
- NF-KappaB Inhibitor alpha
- Nitric Oxide
- Nitric Oxide Synthase Type II
- Nos2 protein, mouse
- Mitogen-Activated Protein Kinases
- Cysteine
- selenomethylselenocysteine
|
Topics |
- Animals
- Anticarcinogenic Agents
(pharmacology)
- Cells, Cultured
- Cysteine
(analogs & derivatives, pharmacology)
- Enzyme Induction
- I-kappa B Proteins
(metabolism)
- Lipopolysaccharides
(antagonists & inhibitors)
- Macrophages
(drug effects, metabolism)
- Mice
- Mitogen-Activated Protein Kinases
(metabolism)
- NF-KappaB Inhibitor alpha
- NF-kappa B
(analysis, metabolism)
- Nitric Oxide
(biosynthesis)
- Nitric Oxide Synthase Type II
(biosynthesis, genetics)
- Organoselenium Compounds
(pharmacology)
- Phosphorylation
- RNA, Messenger
(analysis)
- Selenocysteine
(analogs & derivatives)
|